SlideShare a Scribd company logo
MRS
Dr Prem Kumar C MD
MR techniques
•
•
•
•

Contrast
Diffusion
Perfusion
Spectroscopy

- Vascularity
- Microarchitexture
- Neo angiogenesis
- Chemical environment

• Quantitative noninvasive assay of metabolites
MR SPECTROSCOPY
• Detection of frequency dependent signals from
individual metabolites
• Interpretation is based on identity of chemical
and concentration
• Baseline normal spectra - constant
• Concentration of each metabolites alter in a
reproducible pattern - Abnormal spectra =
DISEASE PATTERN
Variables
• Height
• width

size & Frequency of each peak

• Combining horizontal and vertical information
• Presence / absence of peak
• Ratio of metabolites
METABOLITES
•
•
•
•
•

Cho
- Cell membrane turn over
Cr
- Energy marker -Reference
NAA
- Neuronal cell marker
mI
- Osmolyte
Lactate
- Anerobic state - NOT SEEN
IN NORMAL BRAIN
Hunters angle

Gray matter has
more creatine
NAA Regional Variations
• NAA peak – Highest due to N acetyl group
• Marker of neuronal / axonal viability and
density
• Evenly distributed in Cerebral hemisphere
• Less in hippocampus and cerebellum
• NAA - Neuronal marker
• Decreases with loss of neuronal integrity.
Creatine
•
•
•
•
•
•
•

Energy stores.
Cr 1 - 3.0 ppm
Cr 2 - 3.9 ppm
Marker of intact brain Energy Metabolism.
Reference for interpretation of ratio.
Higher in grey matter than white matter
Higher in thalamus and cerebellum
Choline
•
•
•
•
•

Cho
- 3.2 ppm
Present in Cell membrane
Cell membrane turnover
Choline released during disease from pool
Choline - Increased with increased cellular
turnover
• Elevated in tumors and inflammation
Choline Regional Variations
• Slightly higher in white matter than gray
• Higher in thalamus and cerebellum
• More choline in pons and terminal zones
of myelination
Myo-Inositol
•
•
•
•

Cell Volume Regulator - Osmolyte
mI - 3.5 ppm ; 4.0 ppm.
Present in astrocytes
Astrocyte /glial marker - Product of myelin
degradation
Lactate
•
•
•
•

Accelerated glycolysis /Anaerobic glycolysis
Lac - 1.3 ppm – Doublet
Inverts with TE 144 or 135 ms
Normal in preterm / term infants & CSF
contamination
Lipids
•
•
•
•
•

Lip 1 - 0.9 ppm;
Lip 2 - 1.3 - 1.4 ppm
Broad based
Sign of brain injury
Normally Bound - Not seen
Seen when there is cell death and cell membrane
destruction
• Indicates necrosis and / or disruption of myelin
• Difficult to differentiate from macromolecules
• Non significant lipid – from scalp contamination
Glutamate & Glutamine (Glx)
• Neurotransmitters
• Beta, Gamma Glx - 2.0 - 2.5 ppm
• Alfa Glx - 3.6 - 3.8 ppm
• Glutamine is astrocyte marker
• Glutamate – Neurotransmiter - neurotoxin in
excess amount.
• Main ammonia intake route
• Elevated - In hypoxia, ischemia, recovering
brain.
• Its not a grave prognostic finding like lactate
T2/FLAIR For ROI
MRS acquisition modes
• STEAM -Stimulated echo acquisition mode
• Single voxel
• Short TE
• PRESS -Point resolved spectroscopy
• Twice the SNR of STEAM
• Short and long TE - single voxel possible
PROBE - Single voxel proton MRS
•
•
•
•
•
•

Fully automated prescan, scan
shimming
water suppression
2 -6 minutes Complete acquisition
Short TE (PRESS, STEAM) and
long TE (PRESS)
Single voxel proton MRS
Multi voxel MRS
• Variable voxel sizes
• More than one lesion
• Control from normal
Acquisition Parameters
TR
- 1500 ms
TE
- 35 ms
NAV
- 64
Voxel Size - 2 x 2 x 2 cm
Voxel Location:Cingulate gyrus
-GM
Parietal
-WM
Chemical Shift Imaging in Tumors
Spatial distribution of metabolites
METABOLITES
SHORT TE 35
•
•
•
•

mI
LACTATE
LIPIDS
GLUTAMATE /
GLUTAMINE

BOTH SHORT 35 AND
LONG TE 144
•
•
•
•

NAA
CREATINE
CHOLINE
LACTATE signal
lowered
Lactate Vs Lipid
• Lactate is doublet
• Inversion below the
baseline at 144 ms
• Persists at TE 270 ms.

• Lipid peak is broad
• Has a shoulder to left
• Suppressed at TE 270
ms
TE 35

Lactate

TE 144

TE 270
LIP-LACTATE
Tumor Biochemistry
• Understood by identifying important
metabolites and quantifying them.
• Comparing with normal and benign
tissues, we can understand metabolite
markers and grade them.
Alteration of metabolites in Brain Tumors
• Decreased or absence of N – Acetyl Aspartate (NAA) (Nonneuronal and NAA is only found in neurons)
• Decreased Creatine
• Increased Choline
• Appearance of Lactate (Anaerobic glycolysis)
• Myo-Inositol may distinguish hemangiopericytomas from
meningiomas
• Glutamine and Glutamate are prominent in meningiomas
FAQ
• Is it a tumour
• GBM/ Metz/ Abscess?
• Grade?
• Survival?
• ? Oligodentroglioma?
Tumour?
• D/D -Stroke, Focal cortical dysplasia,
Herpes and Neoplasm
• ^ Cho – Neoplasm
• Always exclude Demylination - ^ Cho
GBM/Metz/Abscess
• Multivoxel PRESS sequence with intermediate
TE -for elevation of Cho in enhancing rim and
in peri-lesional T2 hyperintensity

• If Cho is elevated in both areas - GBM
• Elevated in rim; N –Around - Metz
• Detection of peptides and amino acids in Short
TE - Pyogenic abscess
Grade
• Cho/NAA ratio - Most sensitive
index for tumor cell density and
proliferation.
• Marker of tumor infiltration
• High Cho/NAA and Cho/Cr - Fast
growing and high grade neoplasm
Prognosis
• High Creatine levels in grade II
gliomas- malignant transformation
and poor survival
• High Cho -Pediatric brain tumors
Oligo dentro glioma
Sky-rocketing Choline - high cellular density
MR perfusion:Increased- rCBV- high capillary density
low level of angiogenesis
Low-grade astrocytoma with elevated
lactate
High grade
glial tumors
TE 35
TE 135
57 yr M + LOC

After 20 days
Key points
• High Cho - High tumor cell density & high vascular
proliferation.
• Low Cho and elevation of lipids - Necrosis.
• Cho higher enhancing rim -may be the faster growing
side of the tumor.
• Vasogenic edema -Normal Cho and slightly decreased
NAA.
41y focal seizure

Spectra of active demyelination indistinguishable from
gliomas.
MR perfusion may be helpful.
Tumefactive multiple sclerosis
43 y Focal deficit

• Alanine (Ala) doublet at 1.4 ppm
• Elevation of Cho
• Presence of Lac at 1.3 ppm.
• Absent NAA - Non-neural origin.

• Ala -30–40% of Meningioma
• Mobile lipid and high Cho aggressive lesions
Recurrent astrocytoma
24 y post Rx
Recurrent astrocytoma
•
•
•
•

Normal
-1 Infiltrative
-2
Solid
-3 Early necrotic -4
All with high Cho/ Cr >1.7
High Cho, very low NAA and no lipid -Solid
tumor.
• Small Lac without lipid may be early indicator
of transformation to high grade.
• 51y M, GBM Rx RT.
• Reduced Cho, NAA and
Cr relative to normal brain
indicates necrosis.
Stroke
• Localized decreased NAA - few hours of ischemia.
• Very low or absent – chronic infarcts.
• Lac is elevated in acute stroke due to anaerobic glycolysis in
ischemic brain.
• Creatine and Choline may change in acute and chronic stroke.
• Lipid - Reflect necrosis.
• MRS is added value to diffusion and perfusion
Occlusion of the left ICA /MCA @ 24 h

Left - Elevated Lac and near absent NAA
Occlusion of Right ICA
With in 24 hr

Follow-up @ 1 wk

Follow-up @ 5 m

Lac- Elevated
NAA- Preserved

absence of NAA
Lac in infarct region.
High Cho in peri
infarct WM

Reduced NAA
high Cho in WM
No Lac
Lipid + in infarcted
right basal ganglia.
Pyogenic meningitis

large amount of amino acids -1, lactate -2, alanine -3, acetate -4,acetoacetate -5
Pyogenic abscess

135 TE
Inv Of AA,0.9 ppm, Lac, 1.33 ppm, and Ala, 1.47 ppm peaks
TUBERCULOMA
Tuberculous vs Pyogenic abscesses
• Similar on MRI.
• Tuberculous abscesses - only Lac and lipid signals @
0.9 and 1.3 ppm; No amino acids
• Lipid peaks –In Both tuberculoma and pyogenic
abscess.
• Amino acid signals helps to discriminate pyogenic
from tuberculous abscess

• @ 135 TE Inv of AA- 0.9 ppm
Tuberculous abscesses
STEAM

TE 35, only Lip and Lac at 1.3 ppm.
TE 135 spectrum, phase reversal & reduction in signal
HSE

Findings are due to interstitial edema;

MRS - Non-specific.
Fungal abscess

• TE 135 proton MR spectrum
from core of abscess - inverted
AA and Lac peaks.
• Multiple signal (*) @ 3.6–3.8
ppm- trehalose
Hydatid cyst:
MRS with TE 35 - Lac at 1.33 ppm,
acetate at 1.92 ppm, and succinate at 2.4
ppm;
@TE 135 - Lac and Ala at 1.5 ppm show
phase reversal while Ace and Suc show
normal phase.
Neurocysticercosis
• Spectroscopy may be of value in the large
cysticercus cyst without visible scolex, where
differential diagnosis includes brain abscess
and cystic metastases.
• In vivo MRS shows acetate, succinate and Lac.
• Presence of Cr depending on whether the
lesion is in the vesicular or colloid stage
HIV encephalopathy
• Reductions in NAA and increases in Cho, mI
in both lesional and normal appearing brain
tissues.
• Toxoplasmosis Vs lymphoma
– Toxoplasmosis -Very large lipid signals
– Lymphoma -Large lipid (smaller than toxo)
-High Cho (not seen in toxo).
D/D
Demyelination
Multiple sclerosis -

Axonal damage - Decreased NAA
Demyelination - Increased mI, Cho.
Acute MS plaques Decreased NAA and Cr in large plaques
Increased mI, Cho and Lac
Chronic plaque Cr and Lac return quickly to normal,
Cho
- months to return to normal
NAA -may or may not recover to normal.
Tumefactive demyelination may be similar to neoplasm (elevated Cho, Lac,
decreased NAA) –Perfusion useful.
Monophasic Acute Disseminated Encephalo Myelitis - Mild, reversible NAA
reductions without changes in other metabolites - Good prognosis.
Multiple sclerosis
• Long TE spectra in acute and chronic MS
lesions.
– Both - Elevated Cho and reduced NAA
– Only acute lesion - Elevated lactate

• Short TE spectra from acute lesion and normal
brain for comparison
– Increased mI, choline, and lipids, slightly
decreased Cr and NAA.
Acute Vs Chronic Plaque

• During acute phase- focal increases in Cho and Lac
and decreases in NAA, Cr.
• 15 m later - Reduction of lesion and normalization of
Cho, Cr, and Lactate. NAA- partial recovery.
Seizure disorders
• Help in localize and characterize epileptogenic
foci.
• Helps in lateralizing in temporal lobe epilepsy
• @35TE: Decreased NAA, Increased Cho and
mI - Gliosis
• MRS may help to characterize epileptogenic
lesions visible on MRI (aggressive vs. indolent
neoplasia, dysplasia)
Ipsilat MRS:
Reduced NAA signal and increased Cho
and mI signals- Gliosis

TLE
Helpful in identification of seizure focus in
refractory pts with normal MR

Contralateral MRS:
Reversible with time - transient neuronal
dysfunction.
Bilateral metabolic changes, associated with
poor post-op seizure outcome
Aging and dementia
• Aging - Cho and Cr increase and NAA stable
• AD – Reduced NAA and High mI
• NAA/Cr and mI/Cr ratios correlate with
cognitive function in AD, and this correlation
is more significant with NAA/mI ratios.
• WM NAA/Cr is lower in VaD –than AD
AD
• Progression of AD - Regional
elevation of mI/Cr levels in
prodromal AD

• mI/Cr and NAA/Cr - useful for
predicting and monitoring
prodromal AD.
Neurodegenerative diseases
• Neuronal dysfunction & cell death.
• Metabolite changes in idiopathic Parkinson’s
disease are inconsistent.
• Multiple system atrophy -reduction in NAA
and NAA/Cr ratio when compared with IPD.
• Lactate increased in Huntington’s disease.
Traumatic brain injury
• Conventional CT and MR – major role
• High lactate levels - Poor outcome.
• Visible Lac in normal appearing brain
soon after injury - Poor outcome
• Fall in NAA - Continue for months after
the initial insult.
3 Mon
after
injury
Hypoxic brain injury
• Loss of NAA, increase in Lac and
glutamine and decrease in Cr

• High Lac; low NAA and Cr -Bad
prognosis.
In severe HIE distinction
between poor prognosis
and good prognosis is
made on basis of:

(1) excess Lac
(2) decreased NAA
(3) loss of Cr
Pediatric white matter disease
• Reduced axonal integrity - Reduced
NAA
• Demyelination -High cho and mI
• Hypomyelination or Gliosis -low
Cho, normal NAA
M
L
D

Loss of NAA and elevation of mI
Adrenoleukodystrophy
• Most common leukodystrophy in children
• Zones- demylination, inflamm, gliosis
• MRI often precede clinical symptoms showing
symmetrical WM lesions in parietal and
occipital regions.
• MRS - Onset of demyelination and extent of
WM damage, information for Hemo Stem Cell
Transplant.
Inborn errors of metabolism
• Canavan and Salla disease show an elevated NAA
• Maple syrup urine disease -Branched-chain amino
acids at 0.9 ppm.
• Phenylketonuria -Small phenylalanine signal at
7.36ppm (i.e. downfield of water)
• Non-ketotic hyperglycinemia -Glycine at 3.55 ppm
(use long TE to distinguish from mI)
Canavan’s disease- AR
• Deficiency of aspartoacylase an enzyme that
deacetylates NAA, Increased free acetate
• Hypotonia and macrocephaly
• Symmetrical confluent subcortical WM T2
prolongation & Centripetal spread
• Bilateral involvement of globi pallidi, thalami,
cerebellum and brainstem
NAA is elevated in posterior
sub cortical WM (1) that is
hyper intense on T2 image;
NAA is near normal levels in
(2) is relatively spared by
signal abnormality
Maple syrup urine disease
• Deficiency of branched-chain -keto acid dehydrogenase,
catalyzing essential branched-chain amino acids (BCAA)
isoleucine, leucine and valine.
• Hypertonia and hypotonia, irregular respiration and apnea
• Diffusion restriction compatible with cytotoxic edema in pons,
midbrain, pallidi, thalami, cerebellar, and periventricular WM
• Abnormal peak at 0.9 ppm due to accumulation of lactate
(Lac) and loss of NAA
• Prognostic value & monitor response to Rx / diet
• TE 136 ms- avoids lipids
Elevation of Lac (1.3 ppm) and of the methyl group of BCAA/BCKA (0.9
ppm).
After therapy at day 12 the two abnormal peaks have disappeared.
Phenylketonuria
• Phe hydroxylase def
• Periatrial and periventricular WM symmetrical
hyperintensities.
• Calcifications bilaterally in the globi pallidi
and frontal subcortical regions
• Elevated Phe signal at 7.36 ppm
Phe signal at 7.36 ppm
Non-ketotic hyperglycinemia
• Highly elevated glycine in the CSF and
absence of ketoacidosis
• Large glycine peak at 3.55 ppm
• Long TE is necessary to distinguish glycine
resonance from that of mI at 3.56 ppm which
is normally high in neonates
abnormal elevation of Gly at 3.55 ppm with a Gly/Cr ~ 1.
Progressive decrease of Gly during treatment with a protein restriction diet
Mitochondrial encephalopathy
• Diffuse symmetrical hyperintensity and
volume loss in WM
• mild Lac accumulation in WM, with moderate
NAA and mild Cho and Cr signal losses
Multivoxel TE 136 ms at centrum semiovale level
Thank You

More Related Content

What's hot

Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
Abdellah Nazeer
 

What's hot (20)

MR Elastography
MR ElastographyMR Elastography
MR Elastography
 
Diagnostic Imaging of Intracranial calcifications
Diagnostic Imaging of Intracranial calcificationsDiagnostic Imaging of Intracranial calcifications
Diagnostic Imaging of Intracranial calcifications
 
MR spectroscopy
MR spectroscopyMR spectroscopy
MR spectroscopy
 
MR Spectroscopy
MR SpectroscopyMR Spectroscopy
MR Spectroscopy
 
Basic and advanced mri imaging sequences in brain
Basic and advanced mri imaging sequences in brainBasic and advanced mri imaging sequences in brain
Basic and advanced mri imaging sequences in brain
 
Arterial Spin Labelling in stroke
Arterial Spin Labelling in strokeArterial Spin Labelling in stroke
Arterial Spin Labelling in stroke
 
Resonancia Magnetica
Resonancia Magnetica Resonancia Magnetica
Resonancia Magnetica
 
Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
Presentation1.pptx, diffusion tensor imaging of white matter tract in cerebra...
 
Csf flow study
Csf flow studyCsf flow study
Csf flow study
 
Magnetic resonance spectroscopy
Magnetic resonance spectroscopyMagnetic resonance spectroscopy
Magnetic resonance spectroscopy
 
Diagnostic Imaging of Brain Tumors
Diagnostic Imaging of Brain TumorsDiagnostic Imaging of Brain Tumors
Diagnostic Imaging of Brain Tumors
 
MR spectroscopy
MR spectroscopyMR spectroscopy
MR spectroscopy
 
Skull base imaging
Skull base imagingSkull base imaging
Skull base imaging
 
Diagnostic Imaging of Bilateral Abnormalities of the Basal Ganglia & Thalamus
Diagnostic Imaging of Bilateral Abnormalities of the Basal Ganglia & ThalamusDiagnostic Imaging of Bilateral Abnormalities of the Basal Ganglia & Thalamus
Diagnostic Imaging of Bilateral Abnormalities of the Basal Ganglia & Thalamus
 
MRI spectroscopy- Its Application, Principle & Techniques
MRI spectroscopy- Its Application, Principle & Techniques MRI spectroscopy- Its Application, Principle & Techniques
MRI spectroscopy- Its Application, Principle & Techniques
 
RADIO LOGICAL ANATOMY OF HEAD AND NECK CANCERS
RADIO LOGICAL ANATOMY OF HEAD AND NECK CANCERSRADIO LOGICAL ANATOMY OF HEAD AND NECK CANCERS
RADIO LOGICAL ANATOMY OF HEAD AND NECK CANCERS
 
CT perfusion physics and its application in Neuroimaging
CT perfusion physics and its application in NeuroimagingCT perfusion physics and its application in Neuroimaging
CT perfusion physics and its application in Neuroimaging
 
Magnetic Resonance Angiography and Venography
Magnetic Resonance Angiography and VenographyMagnetic Resonance Angiography and Venography
Magnetic Resonance Angiography and Venography
 
Magnetic Resonance Elastography
Magnetic Resonance ElastographyMagnetic Resonance Elastography
Magnetic Resonance Elastography
 
Radiological anatomy of the brain
Radiological anatomy of the brainRadiological anatomy of the brain
Radiological anatomy of the brain
 

Similar to MRS INTRODUCTION

Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
Monika Nema
 

Similar to MRS INTRODUCTION (20)

Mrs
MrsMrs
Mrs
 
Imaging mrspectroscopy
Imaging mrspectroscopyImaging mrspectroscopy
Imaging mrspectroscopy
 
Mr spectroscopy abdulj original final1
Mr spectroscopy abdulj original  final1Mr spectroscopy abdulj original  final1
Mr spectroscopy abdulj original final1
 
Multiple myeloma dr bikal
Multiple myeloma dr bikalMultiple myeloma dr bikal
Multiple myeloma dr bikal
 
DOC-20230807-WA0039..pdf
DOC-20230807-WA0039..pdfDOC-20230807-WA0039..pdf
DOC-20230807-WA0039..pdf
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Infarction and some important lesions mimicking brain tumour
Infarction and some important lesions mimicking brain tumourInfarction and some important lesions mimicking brain tumour
Infarction and some important lesions mimicking brain tumour
 
Mrs basic principles and clinical applications of magnetic resonance spectros...
Mrs basic principles and clinical applications of magnetic resonance spectros...Mrs basic principles and clinical applications of magnetic resonance spectros...
Mrs basic principles and clinical applications of magnetic resonance spectros...
 
presentation
presentationpresentation
presentation
 
Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
 
ACUTE LEUKAEMIAS IN ADULTS.pptx
ACUTE LEUKAEMIAS IN ADULTS.pptxACUTE LEUKAEMIAS IN ADULTS.pptx
ACUTE LEUKAEMIAS IN ADULTS.pptx
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
clin enzymology.pptx
clin enzymology.pptxclin enzymology.pptx
clin enzymology.pptx
 
Acute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmadaAcute lymphoblastic leukemia dr narmada
Acute lymphoblastic leukemia dr narmada
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Magnetic resonance spectroscopy
Magnetic resonance spectroscopyMagnetic resonance spectroscopy
Magnetic resonance spectroscopy
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Cerebrospinal Fluid (CSF)
Cerebrospinal Fluid (CSF)Cerebrospinal Fluid (CSF)
Cerebrospinal Fluid (CSF)
 
Cardiac bio markers
Cardiac bio markersCardiac bio markers
Cardiac bio markers
 
Acute leukemia.ppt
Acute leukemia.pptAcute leukemia.ppt
Acute leukemia.ppt
 

Recently uploaded

Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
YibeltalNibretu
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 

Recently uploaded (20)

Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
The Benefits and Challenges of Open Educational Resources
The Benefits and Challenges of Open Educational ResourcesThe Benefits and Challenges of Open Educational Resources
The Benefits and Challenges of Open Educational Resources
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matrices
 
Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
Advances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdfAdvances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdf
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptx
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
 
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
 
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdfINU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
 

MRS INTRODUCTION

  • 2. MR techniques • • • • Contrast Diffusion Perfusion Spectroscopy - Vascularity - Microarchitexture - Neo angiogenesis - Chemical environment • Quantitative noninvasive assay of metabolites
  • 3. MR SPECTROSCOPY • Detection of frequency dependent signals from individual metabolites • Interpretation is based on identity of chemical and concentration • Baseline normal spectra - constant • Concentration of each metabolites alter in a reproducible pattern - Abnormal spectra = DISEASE PATTERN
  • 4.
  • 5. Variables • Height • width size & Frequency of each peak • Combining horizontal and vertical information • Presence / absence of peak • Ratio of metabolites
  • 6. METABOLITES • • • • • Cho - Cell membrane turn over Cr - Energy marker -Reference NAA - Neuronal cell marker mI - Osmolyte Lactate - Anerobic state - NOT SEEN IN NORMAL BRAIN
  • 7. Hunters angle Gray matter has more creatine
  • 8.
  • 9.
  • 10. NAA Regional Variations • NAA peak – Highest due to N acetyl group • Marker of neuronal / axonal viability and density • Evenly distributed in Cerebral hemisphere • Less in hippocampus and cerebellum • NAA - Neuronal marker • Decreases with loss of neuronal integrity.
  • 11. Creatine • • • • • • • Energy stores. Cr 1 - 3.0 ppm Cr 2 - 3.9 ppm Marker of intact brain Energy Metabolism. Reference for interpretation of ratio. Higher in grey matter than white matter Higher in thalamus and cerebellum
  • 12. Choline • • • • • Cho - 3.2 ppm Present in Cell membrane Cell membrane turnover Choline released during disease from pool Choline - Increased with increased cellular turnover • Elevated in tumors and inflammation
  • 13. Choline Regional Variations • Slightly higher in white matter than gray • Higher in thalamus and cerebellum • More choline in pons and terminal zones of myelination
  • 14. Myo-Inositol • • • • Cell Volume Regulator - Osmolyte mI - 3.5 ppm ; 4.0 ppm. Present in astrocytes Astrocyte /glial marker - Product of myelin degradation
  • 15. Lactate • • • • Accelerated glycolysis /Anaerobic glycolysis Lac - 1.3 ppm – Doublet Inverts with TE 144 or 135 ms Normal in preterm / term infants & CSF contamination
  • 16. Lipids • • • • • Lip 1 - 0.9 ppm; Lip 2 - 1.3 - 1.4 ppm Broad based Sign of brain injury Normally Bound - Not seen Seen when there is cell death and cell membrane destruction • Indicates necrosis and / or disruption of myelin • Difficult to differentiate from macromolecules • Non significant lipid – from scalp contamination
  • 17. Glutamate & Glutamine (Glx) • Neurotransmitters • Beta, Gamma Glx - 2.0 - 2.5 ppm • Alfa Glx - 3.6 - 3.8 ppm
  • 18. • Glutamine is astrocyte marker • Glutamate – Neurotransmiter - neurotoxin in excess amount. • Main ammonia intake route • Elevated - In hypoxia, ischemia, recovering brain. • Its not a grave prognostic finding like lactate
  • 20. MRS acquisition modes • STEAM -Stimulated echo acquisition mode • Single voxel • Short TE • PRESS -Point resolved spectroscopy • Twice the SNR of STEAM • Short and long TE - single voxel possible
  • 21. PROBE - Single voxel proton MRS • • • • • • Fully automated prescan, scan shimming water suppression 2 -6 minutes Complete acquisition Short TE (PRESS, STEAM) and long TE (PRESS)
  • 23. Multi voxel MRS • Variable voxel sizes • More than one lesion • Control from normal
  • 24. Acquisition Parameters TR - 1500 ms TE - 35 ms NAV - 64 Voxel Size - 2 x 2 x 2 cm Voxel Location:Cingulate gyrus -GM Parietal -WM
  • 25. Chemical Shift Imaging in Tumors Spatial distribution of metabolites
  • 26. METABOLITES SHORT TE 35 • • • • mI LACTATE LIPIDS GLUTAMATE / GLUTAMINE BOTH SHORT 35 AND LONG TE 144 • • • • NAA CREATINE CHOLINE LACTATE signal lowered
  • 27. Lactate Vs Lipid • Lactate is doublet • Inversion below the baseline at 144 ms • Persists at TE 270 ms. • Lipid peak is broad • Has a shoulder to left • Suppressed at TE 270 ms
  • 30. Tumor Biochemistry • Understood by identifying important metabolites and quantifying them. • Comparing with normal and benign tissues, we can understand metabolite markers and grade them.
  • 31. Alteration of metabolites in Brain Tumors • Decreased or absence of N – Acetyl Aspartate (NAA) (Nonneuronal and NAA is only found in neurons) • Decreased Creatine • Increased Choline • Appearance of Lactate (Anaerobic glycolysis) • Myo-Inositol may distinguish hemangiopericytomas from meningiomas • Glutamine and Glutamate are prominent in meningiomas
  • 32. FAQ • Is it a tumour • GBM/ Metz/ Abscess? • Grade? • Survival? • ? Oligodentroglioma?
  • 33. Tumour? • D/D -Stroke, Focal cortical dysplasia, Herpes and Neoplasm • ^ Cho – Neoplasm • Always exclude Demylination - ^ Cho
  • 34. GBM/Metz/Abscess • Multivoxel PRESS sequence with intermediate TE -for elevation of Cho in enhancing rim and in peri-lesional T2 hyperintensity • If Cho is elevated in both areas - GBM • Elevated in rim; N –Around - Metz • Detection of peptides and amino acids in Short TE - Pyogenic abscess
  • 35. Grade • Cho/NAA ratio - Most sensitive index for tumor cell density and proliferation. • Marker of tumor infiltration • High Cho/NAA and Cho/Cr - Fast growing and high grade neoplasm
  • 36.
  • 37.
  • 38. Prognosis • High Creatine levels in grade II gliomas- malignant transformation and poor survival • High Cho -Pediatric brain tumors
  • 39. Oligo dentro glioma Sky-rocketing Choline - high cellular density MR perfusion:Increased- rCBV- high capillary density low level of angiogenesis
  • 40.
  • 41. Low-grade astrocytoma with elevated lactate
  • 43. TE 35
  • 45. 57 yr M + LOC After 20 days
  • 46.
  • 47.
  • 48. Key points • High Cho - High tumor cell density & high vascular proliferation. • Low Cho and elevation of lipids - Necrosis. • Cho higher enhancing rim -may be the faster growing side of the tumor. • Vasogenic edema -Normal Cho and slightly decreased NAA.
  • 49. 41y focal seizure Spectra of active demyelination indistinguishable from gliomas. MR perfusion may be helpful. Tumefactive multiple sclerosis
  • 50. 43 y Focal deficit • Alanine (Ala) doublet at 1.4 ppm • Elevation of Cho • Presence of Lac at 1.3 ppm. • Absent NAA - Non-neural origin. • Ala -30–40% of Meningioma • Mobile lipid and high Cho aggressive lesions
  • 52. Recurrent astrocytoma • • • • Normal -1 Infiltrative -2 Solid -3 Early necrotic -4 All with high Cho/ Cr >1.7 High Cho, very low NAA and no lipid -Solid tumor. • Small Lac without lipid may be early indicator of transformation to high grade.
  • 53. • 51y M, GBM Rx RT. • Reduced Cho, NAA and Cr relative to normal brain indicates necrosis.
  • 54. Stroke • Localized decreased NAA - few hours of ischemia. • Very low or absent – chronic infarcts. • Lac is elevated in acute stroke due to anaerobic glycolysis in ischemic brain. • Creatine and Choline may change in acute and chronic stroke. • Lipid - Reflect necrosis. • MRS is added value to diffusion and perfusion
  • 55. Occlusion of the left ICA /MCA @ 24 h Left - Elevated Lac and near absent NAA
  • 57. With in 24 hr Follow-up @ 1 wk Follow-up @ 5 m Lac- Elevated NAA- Preserved absence of NAA Lac in infarct region. High Cho in peri infarct WM Reduced NAA high Cho in WM No Lac Lipid + in infarcted right basal ganglia.
  • 58. Pyogenic meningitis large amount of amino acids -1, lactate -2, alanine -3, acetate -4,acetoacetate -5
  • 59. Pyogenic abscess 135 TE Inv Of AA,0.9 ppm, Lac, 1.33 ppm, and Ala, 1.47 ppm peaks
  • 61. Tuberculous vs Pyogenic abscesses • Similar on MRI. • Tuberculous abscesses - only Lac and lipid signals @ 0.9 and 1.3 ppm; No amino acids • Lipid peaks –In Both tuberculoma and pyogenic abscess. • Amino acid signals helps to discriminate pyogenic from tuberculous abscess • @ 135 TE Inv of AA- 0.9 ppm
  • 62. Tuberculous abscesses STEAM TE 35, only Lip and Lac at 1.3 ppm. TE 135 spectrum, phase reversal & reduction in signal
  • 63. HSE Findings are due to interstitial edema; MRS - Non-specific.
  • 64. Fungal abscess • TE 135 proton MR spectrum from core of abscess - inverted AA and Lac peaks. • Multiple signal (*) @ 3.6–3.8 ppm- trehalose
  • 65. Hydatid cyst: MRS with TE 35 - Lac at 1.33 ppm, acetate at 1.92 ppm, and succinate at 2.4 ppm; @TE 135 - Lac and Ala at 1.5 ppm show phase reversal while Ace and Suc show normal phase.
  • 66. Neurocysticercosis • Spectroscopy may be of value in the large cysticercus cyst without visible scolex, where differential diagnosis includes brain abscess and cystic metastases. • In vivo MRS shows acetate, succinate and Lac. • Presence of Cr depending on whether the lesion is in the vesicular or colloid stage
  • 67. HIV encephalopathy • Reductions in NAA and increases in Cho, mI in both lesional and normal appearing brain tissues. • Toxoplasmosis Vs lymphoma – Toxoplasmosis -Very large lipid signals – Lymphoma -Large lipid (smaller than toxo) -High Cho (not seen in toxo).
  • 68. D/D
  • 69. Demyelination Multiple sclerosis - Axonal damage - Decreased NAA Demyelination - Increased mI, Cho. Acute MS plaques Decreased NAA and Cr in large plaques Increased mI, Cho and Lac Chronic plaque Cr and Lac return quickly to normal, Cho - months to return to normal NAA -may or may not recover to normal. Tumefactive demyelination may be similar to neoplasm (elevated Cho, Lac, decreased NAA) –Perfusion useful. Monophasic Acute Disseminated Encephalo Myelitis - Mild, reversible NAA reductions without changes in other metabolites - Good prognosis.
  • 70. Multiple sclerosis • Long TE spectra in acute and chronic MS lesions. – Both - Elevated Cho and reduced NAA – Only acute lesion - Elevated lactate • Short TE spectra from acute lesion and normal brain for comparison – Increased mI, choline, and lipids, slightly decreased Cr and NAA.
  • 71.
  • 72. Acute Vs Chronic Plaque • During acute phase- focal increases in Cho and Lac and decreases in NAA, Cr. • 15 m later - Reduction of lesion and normalization of Cho, Cr, and Lactate. NAA- partial recovery.
  • 73. Seizure disorders • Help in localize and characterize epileptogenic foci. • Helps in lateralizing in temporal lobe epilepsy • @35TE: Decreased NAA, Increased Cho and mI - Gliosis • MRS may help to characterize epileptogenic lesions visible on MRI (aggressive vs. indolent neoplasia, dysplasia)
  • 74. Ipsilat MRS: Reduced NAA signal and increased Cho and mI signals- Gliosis TLE Helpful in identification of seizure focus in refractory pts with normal MR Contralateral MRS: Reversible with time - transient neuronal dysfunction. Bilateral metabolic changes, associated with poor post-op seizure outcome
  • 75. Aging and dementia • Aging - Cho and Cr increase and NAA stable • AD – Reduced NAA and High mI • NAA/Cr and mI/Cr ratios correlate with cognitive function in AD, and this correlation is more significant with NAA/mI ratios. • WM NAA/Cr is lower in VaD –than AD
  • 76. AD • Progression of AD - Regional elevation of mI/Cr levels in prodromal AD • mI/Cr and NAA/Cr - useful for predicting and monitoring prodromal AD.
  • 77. Neurodegenerative diseases • Neuronal dysfunction & cell death. • Metabolite changes in idiopathic Parkinson’s disease are inconsistent. • Multiple system atrophy -reduction in NAA and NAA/Cr ratio when compared with IPD. • Lactate increased in Huntington’s disease.
  • 78. Traumatic brain injury • Conventional CT and MR – major role • High lactate levels - Poor outcome. • Visible Lac in normal appearing brain soon after injury - Poor outcome • Fall in NAA - Continue for months after the initial insult.
  • 80. Hypoxic brain injury • Loss of NAA, increase in Lac and glutamine and decrease in Cr • High Lac; low NAA and Cr -Bad prognosis.
  • 81. In severe HIE distinction between poor prognosis and good prognosis is made on basis of: (1) excess Lac (2) decreased NAA (3) loss of Cr
  • 82. Pediatric white matter disease • Reduced axonal integrity - Reduced NAA • Demyelination -High cho and mI • Hypomyelination or Gliosis -low Cho, normal NAA
  • 83. M L D Loss of NAA and elevation of mI
  • 84. Adrenoleukodystrophy • Most common leukodystrophy in children • Zones- demylination, inflamm, gliosis • MRI often precede clinical symptoms showing symmetrical WM lesions in parietal and occipital regions. • MRS - Onset of demyelination and extent of WM damage, information for Hemo Stem Cell Transplant.
  • 85.
  • 86. Inborn errors of metabolism • Canavan and Salla disease show an elevated NAA • Maple syrup urine disease -Branched-chain amino acids at 0.9 ppm. • Phenylketonuria -Small phenylalanine signal at 7.36ppm (i.e. downfield of water) • Non-ketotic hyperglycinemia -Glycine at 3.55 ppm (use long TE to distinguish from mI)
  • 87. Canavan’s disease- AR • Deficiency of aspartoacylase an enzyme that deacetylates NAA, Increased free acetate • Hypotonia and macrocephaly • Symmetrical confluent subcortical WM T2 prolongation & Centripetal spread • Bilateral involvement of globi pallidi, thalami, cerebellum and brainstem
  • 88. NAA is elevated in posterior sub cortical WM (1) that is hyper intense on T2 image; NAA is near normal levels in (2) is relatively spared by signal abnormality
  • 89. Maple syrup urine disease • Deficiency of branched-chain -keto acid dehydrogenase, catalyzing essential branched-chain amino acids (BCAA) isoleucine, leucine and valine. • Hypertonia and hypotonia, irregular respiration and apnea • Diffusion restriction compatible with cytotoxic edema in pons, midbrain, pallidi, thalami, cerebellar, and periventricular WM • Abnormal peak at 0.9 ppm due to accumulation of lactate (Lac) and loss of NAA • Prognostic value & monitor response to Rx / diet • TE 136 ms- avoids lipids
  • 90. Elevation of Lac (1.3 ppm) and of the methyl group of BCAA/BCKA (0.9 ppm). After therapy at day 12 the two abnormal peaks have disappeared.
  • 91. Phenylketonuria • Phe hydroxylase def • Periatrial and periventricular WM symmetrical hyperintensities. • Calcifications bilaterally in the globi pallidi and frontal subcortical regions • Elevated Phe signal at 7.36 ppm
  • 92. Phe signal at 7.36 ppm
  • 93. Non-ketotic hyperglycinemia • Highly elevated glycine in the CSF and absence of ketoacidosis • Large glycine peak at 3.55 ppm • Long TE is necessary to distinguish glycine resonance from that of mI at 3.56 ppm which is normally high in neonates
  • 94. abnormal elevation of Gly at 3.55 ppm with a Gly/Cr ~ 1. Progressive decrease of Gly during treatment with a protein restriction diet
  • 95. Mitochondrial encephalopathy • Diffuse symmetrical hyperintensity and volume loss in WM • mild Lac accumulation in WM, with moderate NAA and mild Cho and Cr signal losses
  • 96. Multivoxel TE 136 ms at centrum semiovale level